Market Pulse
Arqiva announces plans for London listing
Broadcast and mobile masts company Arqiva has announced its intention to float on the London Stock Exchange in a £6bn listing.
Essentra returns to revenue growth, but profits hit by hurricanes
In the third quarter Essentra returned to like-for-like revenue growth for the first time in almost two years, though full year margins for the plastics and packaging group will be dented by the impact of Hurricane Maria on its Puerto Rico sites.
Clinigen buys Japanese medicine supplier
AIM-listed pharmaceutical and services company Clinigen has acquired International Medical Management Corporation (IMMC), Japan's largest supplier of unlicensed medicines, for an undisclosed sum.
Petra revenue and production drop on diamonds seizure, labour disruptions
Petra Diamonds posted a 4% drop in production and a 17% decline in revenue for the first quarter.
Interserve secures £140m contract extension with BBC
Support services and construction group Interserve has won a £140m contract with the BBC to continue providing facilities services until 2023.
London open: Stocks dip down in quiet start to busy week
London stocks nudged lower in early trade amid a lack of market-moving news, with the economic calendar set to get busier later in the week.
Capita's sale of Asset Services arm nears completion
Capita expects to complete the sale of its Asset Services businesses to Link Administration a week on Friday.
Electra Private Equity eyes new flexible approach, declares another dividend
After completing a strategic review and reverted to internal management of its investments, Electra Private Equity has decided "current market conditions do not support new investment" and so proposed handing back most of its cash and dropping its focus on private equity to become "more flexible".
CRH gets shareholder approval for Ash Grove deal
Building materials company CRH is set to push ahead with its $3. 5bn acquisition of US cement manufacturer Ash Grove Cement after receiving shareholder approval for the deal.
AstraZeneca diabetes drug gets FDA approval
AstraZeneca said that the US Food and Drug Administration has approved a new formulation of its type-2 diabetes treatment Bydureon.
GlaxoSmithKline's Shingrix gets US FDA approval
GlaxoSmithKline said on Monday that the US Food and Drug Administration has approved Shingrix for the prevention of shingles in adults over 50.
Renewi sees full-year results 'significantly above' previous expectations
Waste-to-product business Renewi said on Monday that results for the year are expected to be “significantly above” its previous expectations following a particularly strong performance in September.
London pre-open: Stocks to nudge lower as pound gains ground
London stocks were set to nudge a touch lower at the open on Monday as the pound gains ground against the dollar and the euro.
Monday newspaper round-up: Budget crunch, wages, manufacturers, GKN, Spire, BT
Philip Hammond has been warned by cabinet colleagues that he faces an ambush on the budget from Tories who want him out. Senior government figures fear that the chancellor has become so toxic that he does not have sufficient authority to get difficult measures through the Commons. - The Times.